# Telaprevir With Peginterferon Alfa & Ribavirin in Ex-People Who INject Drugs Infected by Genotype 1 Chronic Hepatitis C

> **NCT01980290** · — · COMPLETED · sponsor: **Janssen Pharmaceutica N.V., Belgium** · enrollment: 50 (actual)

## Conditions studied

- Hepatitis, Chronic

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01980290
- **Lead sponsor:** Janssen Pharmaceutica N.V., Belgium
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2015-02
- **Final completion:** 2015-02
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2017-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01980290

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01980290, "Telaprevir With Peginterferon Alfa & Ribavirin in Ex-People Who INject Drugs Infected by Genotype 1 Chronic Hepatitis C". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01980290. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*